MRI Interventions Inc (MRIC):企業の財務・戦略的SWOT分析

◆英語タイトル:MRI Interventions Inc (MRIC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14463
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treating neurological and cardiac diseases. MRI Interventions’ product provides real time MRI assistance for certain invasive procedures in the brain. The company has partnership with various medical device companies and academic institutions for the development and commercialization of its product platforms and core technologies. It serves physicians and hospitals. MRI Interventions is headquartered in Irvine, California, the US.

MRI Interventions Inc Key Recent Developments

Nov 12,2018: MRI Interventions Reports Record ClearPoint Cases and Disposable Functional Neurosurgery Revenue in Third Quarter
Nov 06,2018: MRI Interventions Announces FDA Clearance of ClearPoint® 2.0 Next-Generation Software Platform
Nov 05,2018: MRI Interventions, Inc. to Announce Third Quarter 2018 Results on November 12
Oct 19,2018: MRI Interventions Signs Exclusive Distribution Agreement with Clinical Laserthermia Systems (CLS) for U.S. and Canada
Oct 17,2018: Clinical Laserthermia Systems (CLS) Signs Exclusive Distribution Agreement with MRI Interventions for USA and Canada

This comprehensive SWOT profile of MRI Interventions Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MRI Interventions Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

MRI Interventions Inc – Key Information
MRI Interventions Inc – Overview
MRI Interventions Inc – Key Employees
MRI Interventions Inc – Key Employee Biographies
MRI Interventions Inc – Key Operational Heads
MRI Interventions Inc – Major Products and Services
MRI Interventions Inc – History
MRI Interventions Inc – Company Statement
MRI Interventions Inc – Locations And Subsidiaries
MRI Interventions Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

MRI Interventions Inc – Business Description
MRI Interventions Inc – Corporate Strategy
MRI Interventions Inc – SWOT Analysis
SWOT Analysis – Overview
MRI Interventions Inc – Strengths
MRI Interventions Inc – Weaknesses
MRI Interventions Inc – Opportunities
MRI Interventions Inc – Threats
MRI Interventions Inc – Key Competitors

Section 3 – Company Financial Performance Charts

MRI Interventions Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

MRI Interventions Inc, Key Information
MRI Interventions Inc, Key Ratios
MRI Interventions Inc, Share Data
MRI Interventions Inc, Major Products and Services
MRI Interventions Inc, History
MRI Interventions Inc, Key Employees
MRI Interventions Inc, Key Employee Biographies
MRI Interventions Inc, Key Operational Heads
MRI Interventions Inc, Other Locations
MRI Interventions Inc, Subsidiaries
MRI Interventions Inc, Key Manufacturing facilities
MRI Interventions Inc, Key Competitors
MRI Interventions Inc, SWOT Analysis
MRI Interventions Inc, Ratios based on current share price
MRI Interventions Inc, Annual Ratios
MRI Interventions Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

MRI Interventions Inc, Performance Chart
MRI Interventions Inc, Ratio Charts

★海外企業調査レポート[MRI Interventions Inc (MRIC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pure Technologies Ltd:企業の戦略的SWOT分析
    Pure Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Formycon AG (FYB):企業の財務・戦略的SWOT分析
    Summary Formycon AG (Formycon) formerly Nanohale AG is a biopharmaceutical company that develops biosimilar drugs candidates. The company offers biopharmaceutical imitation products for global recovery. It provides four biosimilar products in pre-clinical and clinical testing phases. Formycon’s pipe …
  • Robert Bosch GmbH:企業の戦略的SWOT分析
    Robert Bosch GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Morepen Laboratories Ltd (MOREPENLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Morepen Laboratories Ltd (Morepen Laboratories) is a manufacturer and supplier of active pharma ingredients and formulations. The company offers active pharma ingredients, formulation and homehealth solutions. It offers products in forms of tablets, capsules, liquids and powders. Morepen Lab …
  • B. Braun Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary B. Braun Medical Inc (B. Braun), a subsidiary of B. Braun Melsungen AG, is a medical device company that provides infusion therapy and pain management technology, products and services. The company’s product portfolio includes TPN compounding bags, parenteral nutrition additives, closed syst …
  • Heineken NV:企業の戦略・SWOT・財務分析
    Heineken NV - Strategy, SWOT and Corporate Finance Report Summary Heineken NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Garanti Technology:企業の戦略・SWOT・財務情報
    Garanti Technology - Strategy, SWOT and Corporate Finance Report Summary Garanti Technology - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Medline Industries, Inc.:企業の戦略・SWOT・財務分析
    Medline Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Medline Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Christian Dior SE:戦略・SWOT・企業財務分析
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cosmos Insurance Public Company Ltd:企業の戦略・SWOT・財務分析
    Cosmos Insurance Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosmos Insurance Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • EnerNOC, Inc.-エネルギー分野:企業M&A・提携分析
    Summary EnerNOC, Inc. (EnerNOC), formerly EnerNOC, LLC, is a provider of energy intelligence software (EIS) and demand response solutions. The company’s EIS offers enterprise customers with Software-as-a-Service (SaaS) solutions with various areas of functionalities. It offers SaaS solutions to mana …
  • ContraFect Corp (CFRX):企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) is a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases. …
  • Bachmann electronic GmbH:企業の戦略的SWOT分析
    Bachmann electronic GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Culp Inc (CULP):企業の財務・戦略的SWOT分析
    Culp Inc (CULP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rubis SCA (RUI):石油・ガス:M&Aディール及び事業提携情報
    Summary Rubis SCA (Rubis) is an independent downstream company that carries out the storage, distribution and trading of bulk petroleum and chemical products. Its product portfolio includes fuel oil, liquefied petroleum gas (LPG), gasoline, diesel, home heating oil, chemical products, edible oils, m …
  • Apotex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and d …
  • Banco Pan S.A. (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan S.A. (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • LCH.Clearnet Group Limited:企業の戦略・SWOT・財務情報
    LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report Summary LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆